Cargando…

Atopic Dermatitis: Background, Objectives and Future Perspectives (Superresponders)

Detalles Bibliográficos
Autores principales:	Ruiz-Villaverde, Ricardo, Domínguez-Cruz, Javier, Navarro-Triviño, Francisco J., Galán-Gutiérrez, Manuel, Armario-Hita, Jose Carlos, Pereyra-Rodriguez, Jose Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410156/ https://www.ncbi.nlm.nih.gov/pubmed/36013371 http://dx.doi.org/10.3390/life12081192

Ejemplares similares

Validation of a Questionnaire to Assess the Perception of Women with Atopic Dermatitis in Family Planning
por: Alcantara-Luna, Sara, et al.
Publicado: (2022)

104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain()()
por: Pereyra-Rodriguez, Jose Juan, et al.
Publicado: (2021)

Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review
por: Ayen-Rodríguez, Angela, et al.
Publicado: (2022)

Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis
por: Pereyra-Rodriguez, José-Juan, et al.
Publicado: (2021)

Severe Atopic Dermatitis In Spain: A Real-Life Observational Study
por: Sicras-Mainar, Antoni, et al.
Publicado: (2019)

Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus
por: PEREYRA-RODRIGUEZ, Jose J., et al.
Publicado: (2023)

Cardiac contractility modulation therapy: Are there superresponders?
por: Al-Ghamdi, Bandar, et al.
Publicado: (2017)

Super-Responders in Moderate–Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives
por: Ruiz-Villaverde, Ricardo, et al.
Publicado: (2022)

Contact Vitiligo Following Allergic Contact Dermatitis
por: Ruiz-Villaverde, Ricardo, et al.
Publicado: (2022)

Effectiveness, survival and safety of guselkumab attending to basal characteristics in moderate-to-severe psoriatic patients: a cohort study
por: Ruiz-Villaverde, Ricardo, et al.
Publicado: (2022)

Sexual Dysfunction and Atopic Dermatitis: A Systematic Review
por: Linares-Gonzalez, Laura, et al.
Publicado: (2021)

Consensus on the Clinical Approach to Moderate-to-Severe Atopic Dermatitis in Spain: A Delphi Survey
por: Sastre, Joaquín, et al.
Publicado: (2020)

Bullous Allergic Contact Dermatitis Caused by Potassium Dichromate
por: Navarro-Triviño, Francisco J., et al.
Publicado: (2023)

Study of Hypersensitivity to Malassezia furfur in Patients with Atopic Dermatitis with Head and Neck Pattern: Is It Useful as a Biomarker and Therapeutic Indicator in These Patients?
por: Navarro-Triviño, Francisco José, et al.
Publicado: (2022)

Challenges and Future Trends in Atopic Dermatitis
por: Gatmaitan, Julius Garcia, et al.
Publicado: (2023)

Emerging Methods to Objectively Assess Pruritus in Atopic Dermatitis
por: Smith, Mary Patricia, et al.
Publicado: (2019)

Calcipotriol/Betamethasone Dipropionate Aerosol Foam for Plaque Psoriasis: A Prospective, Observational, Non-Interventional, Single-Center Study of Patient Adherence and Satisfaction in Daily Use
por: Navarro-Triviño, Francisco José, et al.
Publicado: (2021)

Photosensitive rash induced by nivolumab()
por: Navarro-Triviño, Francisco J., et al.
Publicado: (2022)

Lichenoid drug eruption induced by pravastatin; it is possible to prescribe other statins?()
por: Navarro-Triviño, Francisco J., et al.
Publicado: (2023)

Old World Cutaneous Leishmaniasis: Successful response to topical imiquimod
por: Llamas-Molina, Jose M., et al.
Publicado: (2022)

Signs of atopic dermatitis and contact dermatitis affected by distinct H2-haplotype in the NC/Nga genetic background
por: Ohkusu-Tsukada, Kozo, et al.
Publicado: (2018)

Genetics in Atopic Dermatitis: Historical Perspective and Future Prospects
por: BROWN, Sara J., et al.
Publicado: (2020)

Atopic dermatitis
por: Werfel, Thomas
Publicado: (2011)

Atopic dermatitis
por: Watson, Wade, et al.
Publicado: (2011)

Atopic dermatitis
por: Kapur, Sandeep, et al.
Publicado: (2018)

Atopic dermatitis
por: Galli, Elena, et al.
Publicado: (2020)

Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023)

Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
por: Gelato, Federica, et al.
Publicado: (2023)

Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis?
por: Gaspar, Neide Kalil, et al.
Publicado: (2016)

Dragon Warts
por: Linares-Gonzalez, Laura, et al.
Publicado: (2020)

Optimising the Therapeutic Interval for Biologics in Patients with Psoriasis
por: Dodero-Anillo, Jose Manuel, et al.
Publicado: (2022)

Overview of atopic dermatitis
por: Kim, Kyu Han
Publicado: (2013)

Atopic dermatitis in adolescence
por: Ricci, Giampaolo, et al.
Publicado: (2011)

Prevention of atopic dermatitis
por: Williams, Hywel C., et al.
Publicado: (2012)

Autoallergy in atopic dermatitis
por: Hradetzky, Susanne, et al.
Publicado: (2015)

Psoriasis and Atopic Dermatitis
por: Griffiths, Christopher E. M., et al.
Publicado: (2017)

Microbiome in atopic dermatitis
por: Wollina, Uwe
Publicado: (2017)

Atopic Dermatitis and Comorbidity
por: Bekić, Sanja, et al.
Publicado: (2020)

Autoimmunity (or Not) in Atopic Dermatitis
por: Roesner, Lennart M., et al.
Publicado: (2019)

The exposome in atopic dermatitis
por: Stefanovic, Nicholas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_epqolaf20mkk1ggb8mi6caloc4